Integrative Psychiatry of America, MD

Integrative Psychiatry of America is a Pennsylvania-based telehealth psychiatry practice that combines conventional psychiatric medication management with evidence-informed integrative medicine tools — including pharmacogenomic genetic testing, advanced laboratory screening, nutritional counseling, and mindfulness-based interventions — to offer a more comprehensive approach to mental health treatment than medication-only models typically provide. The practice treats a range of psychiatric conditions including ADHD, anxiety disorders, depression, OCD, PTSD, personality disorders, and addiction, as well as weight management. Its integrative approach means that a patient presenting with ADHD might receive not only an evaluation for stimulant medication but also a genetic test to predict metabolism of psychiatric medications, an order for thyroid and metabolic labs to rule out physiological contributors to inattention, and personalized recommendations for exercise programming and dietary adjustment that evidence suggests improve executive function. Pharmacogenomic testing — typically using platforms like GeneSight or similar tools — analyzes genetic variants that influence how individuals metabolize and respond to psychiatric medications. This information can be particularly valuable for patients who have tried multiple ADHD medications without success, experienced unexpected side effects, or have family histories suggesting atypical drug metabolism. By incorporating this testing into the initial evaluation workflow, IPA reduces the trial-and-error period that many ADHD patients experience before finding an effective medication regimen. The practice accepts most major insurance plans, which meaningfully lowers the barrier to care compared to the private-pay psychiatric model. This is clinically significant because integrative psychiatry services — particularly those incorporating genetic testing and advanced labs — are typically found in cash-pay concierge practices that are accessible only to affluent patients. IPA's insurance acceptance allows patients without substantial disposable income to access a level of clinical sophistication that would otherwise require paying out-of-pocket. All care is delivered via secure telehealth video, serving Pennsylvania residents only. This geographic limitation reflects the practice's focus on building deep relationships with patients rather than scaling nationally on a platform model. The practice treats a range of psychiatric conditions including ADHD, anxiety disorders, depression, OCD, PTSD, personality disorders, and addiction, as well as weight management. Its integrative approach means that a patient presenting with ADHD might receive not only an evaluation for stimulant medication but also a genetic test to predict metabolism of psychiatric medications, an order for thyroid and metabolic labs to rule out physiological contributors to inattention, and personalized recommendations for exercise programming and dietary adjustment that evidence suggests improve executive function. Pharmacogenomic testing — typically using platforms like GeneSight or similar tools — analyzes genetic variants that influence how individuals metabolize and respond to psychiatric medications. This information can be particularly valuable for patients who have tried multiple ADHD medications without success, experienced unexpected side effects, or have family histories suggesting atypical drug metabolism. By incorporating this testing into the initial evaluation workflow, IPA reduces the trial-and-error period that many ADHD patients experience before finding an effective medication regimen. The practice accepts most major insurance plans, which meaningfully lowers the barrier to care compared to the private-pay psychiatric model. This is clinically significant because integrative psychiatry services — particularly those incorporating genetic testing and advanced labs — are typically found in cash-pay concierge practices that are accessible only to affluent patients. IPA's insurance acceptance allows patients without substantial disposable income to access a level of clinical sophistication that would otherwise require paying out-of-pocket. All care is delivered via secure telehealth video, serving Pennsylvania residents only. This geographic limitation reflects the practice's focus on building deep relationships with patients rather than scaling nationally on a platform model.